てんかんモニタリングデバイスの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2024年～2030年

てんかんモニタリングデバイスの市場動向

てんかんモニタリングデバイスの世界市場規模は、2023年に5億5,900万米ドルと推定され、2024～2030年にかけてCAGR 6.6%で成長すると予測されています。この市場は、てんかんの有病率の増加、技術の進歩、外来モニタリングの需要増加、ウェアラブルデバイスの使用増加、政府のイニシアチブの高まりなど、いくつかの要因によって牽引されています。

さらに、診断と治療の改善に対するニーズの高まり、市場競争の激化、遠隔医療の重要性の高まりも、市場成長を後押しする主要要因の1つです。てんかんの有病率は世界的に増加しており、罹患者数は全世界で相当数に上ります。

世界保健機関（WHO）によると、てんかんは世界中で推定5,000万人が罹患する神経疾患であり、世界的に最も一般的な慢性疾患の1つとなっています。同報告書によると、てんかん患者の約80%は低・中所得国（LMIC）に住んでおり、質の高い医療へのアクセスが制限されていることが多いです。てんかんは繰り返し発作を起こすことが特徴で、患者の生活の質に大きな影響を与えます。てんかんの効果的な診断と治療には、発作をリアルタイムで検出・追跡できる高度なモニタリングデバイスが必要です。

米国だけでも、てんかん患者数は300万人を超えると推定されています。さらに、米国疾病予防管理センターによると、2021年には、18歳以上の米国成人約290万人が活動性てんかんであると報告しています。

ウェアラブル技術とデータ分析の進歩は、てんかんモニタリングデバイスのセグメントに革命をもたらしました。発作検出アルゴリズムを搭載したスマートウォッチやフィットネストラッカーの採用より、心拍数、運動、皮膚電気活動を含む患者の生理学的データの継続的モニタリングが可能になりました。これにより、潜在的な発作エピソードをリアルタイムで検出することが可能となり、患者や医療プロバイダーにタイムリーで正確な情報を提供し、治療や管理について十分な情報に基づいた意思決定を行うことができます。例えば、2024年2月、神経疾患の継続的、非侵襲的、目立たないモニタリングのパイオニア企業であるEmpatica Inc.は、EpiMonitorの発売を発表しました。このウェアラブルてんかんモニタリングソリューションの最新イノベーションは、6歳以上の成人と小児向けに設計されており、発作の検出と管理に比類のない利便性と精度を提供する最先端技術を備えています。

さらに、てんかん研究への資金提供や投資といった政府の取り組みが活発化していることも、予測期間中の市場の成長を後押しすると予想されます。例えば、Epilepsy Research Institute UKは、英国政府がMedical Research Charities Early Career Researchers Support Fundを通じてEpilepsy Research UKに189万米ドル以上の助成金を投資したと発表しました。この慈善団体は、2022～23年に135万米ドル、2021～22年に56万2,010.5米ドルを受け取った。さらに、2024年3月、英国てんかん協会は、がん、認知症、てんかんの調査に4,866万米ドルを投資すると発表しました。

てんかんモニタリングデバイスの世界市場セグメンテーションレポート

本レポートでは、世界、地域、国レベルで収益成長を予測し、2018～2030年の各サブセグメントにおける最新の業界動向分析を提供しています。この調査において、Grand View Research, Inc.は、てんかんモニタリングデバイスの世界市場レポートを製品、最終用途、地域に基づいてセグメント化しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブ概要

第3章 てんかんモニタリングデバイス市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• てんかんモニタリングデバイス市場分析ツール
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 てんかんモニタリングデバイス市場：製品、推定・動向分析

• 製品市場シェア、2023年と2030年
• セグメントダッシュボード
• 製品別の世界のてんかんモニタリングデバイス市場展望
• 2018～2030年の市場規模と予測と動向分析

第5章 てんかんモニタリングデバイス市場：最終用途、推定・動向分析

• 最終用途市場シェア、2023年と2030年
• セグメントダッシュボード
• 最終用途別の世界のてんかんモニタリングデバイス市場展望
• 2018～2030年の市場規模と予測と動向分析

第6章 てんかんモニタリングデバイス市場：地域推定・動向分析

• 地域別市場シェア分析、2023年と2030年
• 地域市場ダッシュボード
• 世界地域市場スナップショット
• 市場規模、予測動向分析、2018～2030年：
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要企業の市場シェア分析、2023年
  • NIHON KOHDEN CORPORATION
  • Medtronic
  • GE Healthcare
  • Koninklijke Philips NV
  • Compumedics Limited
  • Natsu Medical
  • Cadwell Industries, Inc.
  • BrainScope Company, Inc.
  • Seer Medical
  • Stratus

List of Tables

• Table 1 List of abbreviation
• Table 2 North America epilepsy monitoring devices market, by region, 2018 - 2030 (USD Million)
• Table 3 North America epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 4 North America epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 5 U.S. epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 6 U.S. epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 7 Canada epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 8 Canada epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 9 Mexico epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 10 Mexico epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 11 Europe epilepsy monitoring devices market, by region, 2018 - 2030 (USD Million)
• Table 12 Europe epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 13 Europe epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 14 Germany epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 15 Germany epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 16 UK epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 17 UK epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 18 France epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 19 France epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 20 Italy epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 21 Italy epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 22 Spain epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 23 Spain epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 24 Denmark epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 25 Denmark epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 26 Sweden epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 27 Sweden epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 28 Norway epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 29 Norway epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 30 Asia Pacific epilepsy monitoring devices market, by region, 2018 - 2030 (USD Million)
• Table 31 Asia Pacific epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 32 Asia Pacific epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 33 China epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 34 China epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 35 Japan epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 36 Japan epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 37 India epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 38 India epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 39 South Korea epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 40 South Korea epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 41 Australia epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 42 Australia epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 43 Thailand epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 44 Thailand epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 45 Latin America epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 46 Latin America epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 47 Brazil epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 48 Brazil epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 49 Argentina epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 50 Argentina epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 51 MEA epilepsy monitoring devices market, by region, 2018 - 2030 (USD Million)
• Table 52 MEA epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 53 MEA epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 54 South Africa epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 55 South Africa epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 56 Saudi Arabia epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 57 Saudi Arabia epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 58 UAE epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 59 UAE epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)
• Table 60 Kuwait epilepsy monitoring devices market, by product, 2018 - 2030 (USD Million)
• Table 61 Kuwait epilepsy monitoring devices market, by end use, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Primary interviews in North America

Fig. 5 Primary interviews in Europe

Fig. 6 Primary interviews in APAC

Fig. 7 Primary interviews in Latin America

Fig. 8 Primary interviews in MEA

Fig. 9 Market research approaches

Fig. 10 Value-chain-based sizing & forecasting

Fig. 11 QFD modeling for market share assessment

Fig. 12 Market formulation & validation

Fig. 13 Epilepsy monitoring devices market: market outlook

Fig. 14 Epilepsy monitoring devices competitive insights

Fig. 15 Parent market outlook

Fig. 16 Related/ancillary market outlook

Fig. 17 Penetration and growth prospect mapping

Fig. 18 Industry value chain analysis

Fig. 19 Epilepsy monitoring devices market driver impact

Fig. 20 Epilepsy monitoring devices market restraint impact

Fig. 21 Epilepsy monitoring devices market strategic initiatives analysis

Fig. 22 Epilepsy monitoring devices market: Product movement analysis

Fig. 23 Epilepsy monitoring devices market: Product outlook and key takeaways

Fig. 24 Wearable devices market estimates and forecast, 2018 - 2030

Fig. 25 Conventional devices market estimates and forecast, 2018 - 2030

Fig. 26 Epilepsy monitoring devices market: End use movement analysis

Fig. 27 Epilepsy monitoring devices market: End use outlook and key takeaways

Fig. 28 Hospitals & clinics market estimates and forecasts,2018 - 2030

Fig. 29 Ambulatory surgical centers market estimates and forecasts,2018 - 2030

Fig. 30 Neurology centers market estimates and forecasts,2018 - 2030

Fig. 31 Diagnostic centers market estimates and forecasts, 2018 - 2030

Fig. 32 Global Epilepsy monitoring devices market: Regional movement analysis

Fig. 33 Global Epilepsy monitoring devices market: Regional outlook and key takeaways

Fig. 34 Global Epilepsy monitoring devices market share and leading players

Fig. 35 North America market share and leading players

Fig. 36 Europe market share and leading players

Fig. 37 Asia Pacific market share and leading players

Fig. 38 Latin America market share and leading players

Fig. 39 Middle East & Africa market share and leading players

Fig. 40 North America, by country

Fig. 41 North America

Fig. 42 North America market estimates and forecasts, 2018 - 2030

Fig. 43 U.S. key country dynamics

Fig. 44 U.S. market estimates and forecasts, 2018 - 2030

Fig. 45 Canada key country dynamics

Fig. 46 Canada market estimates and forecasts, 2018 - 2030

Fig. 47 Mexico key country dynamics

Fig. 48 Mexico market estimates and forecasts, 2018 - 2030

Fig. 49 Europe

Fig. 50 Europe market estimates and forecasts, 2018 - 2030

Fig. 51 UK key country dynamics

Fig. 52 UK market estimates and forecasts, 2018 - 2030

Fig. 53 Germany key country dynamics

Fig. 54 Germany market estimates and forecasts, 2018 - 2030

Fig. 55 France key country dynamics

Fig. 56 France market estimates and forecasts, 2018 - 2030

Fig. 57 Italy key country dynamics

Fig. 58 Italy market estimates and forecasts, 2018 - 2030

Fig. 59 Spain key country dynamics

Fig. 60 Spain market estimates and forecasts, 2018 - 2030

Fig. 61 Denmark key country dynamics

Fig. 62 Denmark market estimates and forecasts, 2018 - 2030

Fig. 63 Sweden key country dynamics

Fig. 64 Sweden market estimates and forecasts, 2018 - 2030

Fig. 65 Norway key country dynamics

Fig. 66 Norway market estimates and forecasts, 2018 - 2030

Fig. 67 Asia Pacific

Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030

Fig. 69 China key country dynamics

Fig. 70 China market estimates and forecasts, 2018 - 2030

Fig. 71 Japan key country dynamics

Fig. 72 Japan market estimates and forecasts, 2018 - 2030

Fig. 73 India key country dynamics

Fig. 74 India market estimates and forecasts, 2018 - 2030

Fig. 75 Australia key country dynamics

Fig. 76 Australia market estimates and forecasts, 2018 - 2030

Fig. 77 South Korea key country dynamics

Fig. 78 South Korea market estimates and forecasts, 2018 - 2030

Fig. 79 Thailand key country dynamics

Fig. 80 Thailand market estimates and forecasts, 2018 - 2030

Fig. 81 Latin America

Fig. 82 Latin America market estimates and forecasts, 2018 - 2030

Fig. 83 Brazil key country dynamics

Fig. 84 Brazil market estimates and forecasts, 2018 - 2030

Fig. 85 Argentina key country dynamics

Fig. 86 Argentina market estimates and forecasts, 2018 - 2030

Fig. 87 Middle East and Africa

Fig. 88 Middle East and Africa market estimates and forecasts, 2018 - 2030

Fig. 89 South Africa key country dynamics

Fig. 90 South Africa market estimates and forecasts, 2018 - 2030

Fig. 91 Saudi Arabia key country dynamics

Fig. 92 Saudi Arabia market estimates and forecasts, 2018 - 2030

Fig. 93 UAE key country dynamics

Fig. 94 UAE market estimates and forecasts, 2018 - 2030

Fig. 95 Kuwait key country dynamics

Fig. 96 Kuwait market estimates and forecasts, 2018 - 2030

Fig. 97 Market share of key market players- Epilepsy monitoring devices market

Epilepsy Monitoring Devices Market Trends

The global epilepsy monitoring devices market size was estimated at USD 559.0 million in 2023 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. The market is driven by several factors, such as the increasing prevalence of epilepsy, advances in technology, growing demand for ambulatory monitoring, rising use of wearable devices, and growing government initiatives.

Further, the increasing need for improved diagnosis and treatment, growing competition, and growing importance of telemedicine are also some of the primary factors fueling the market growth. The prevalence of epilepsy is increasing globally, with a significant number of people affected worldwide.

Epilepsy is a neurological disorder that affects an estimated 50 million people worldwide, making it one of the most common chronic conditions globally, according to the World Health Organization (WHO). According to the same report, around 80% of people with epilepsy live in low- and middle-income countries (LMIC), where access to quality healthcare is often limited. The condition is characterized by recurring seizures, which can have a significant impact on a person's quality of life. Effective diagnosis and treatment of epilepsy require advanced monitoring devices that can detect and track seizures in real-time.

In the U.S. alone, over 3 million individuals are estimated to be living with epilepsy. Further, in 2021, about 2.9 million U.S. adults 18 and older reported having active epilepsy, as per the U.S. Centers for Disease Control and Prevention.

The advancement of wearable technology and data analytics has revolutionized the field of epilepsy monitoring devices. The introduction of smartwatches and fitness trackers equipped with seizure detection algorithms has enabled the continuous monitoring of a patient's physiological data, including heart rate, movement, and electrodermal activity. This allows for detecting potential seizure episodes in real-time, providing patients and healthcare providers with timely and accurate information to make informed decisions about treatment and management. For instance, in February 2024, Empatica Inc., a pioneering company in continuous, non-invasive, and discreet monitoring for neurological conditions, announced the launch of EpiMonitor. This latest innovation in wearable epilepsy monitoring solutions is designed for adults and children aged 6 and above, offering cutting-edge technology that provides unparalleled convenience and accuracy in detecting and managing seizures.

Furthermore, growing government initiatives such as funding and investments for epilepsy research are expected to fuel the market's growth over the forecast period. For instance, Epilepsy Research Institute UK announced that the UK government has invested over USD 1.89 million in grant funding into Epilepsy Research UK through its Medical Research Charities Early Career Researchers Support Fund. The charity received USD 1.35 million in 2022-23 and USD 562,010.5 in 2021-22. Further, in March 2024, the British Epilepsy Association announced a USD 48.66 million investment into research for cancer, dementia, and epilepsy.

Global Epilepsy Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global epilepsy monitoring devices market report based on product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Wearable Devices
• Conventional Devices
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Neurology Centers
• Diagnostic Centers
• Regional Outlook (Revenue in USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

• Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

• Latin America

Brazil

Argentina

• Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End Use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Epilepsy Monitoring Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising incidents of venom-bites
    • 3.2.1.2. Increasing R&D initiatives
    • 3.2.1.3. Increasing awareness about importance of Epilepsy monitoring devices
    • 3.2.1.4. Rising government initiatives
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited access to the treatments
• 3.3. Epilepsy monitoring devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Epilepsy Monitoring Devices Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Epilepsy Monitoring Devices Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Wearable Devices
    • 4.4.1.1. Wearable devices market estimates and forecasts 2018 to 2030, (USD Million)
  • 4.4.2. Conventional Devices
    • 4.4.2.1. Conventional devices market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 5. Epilepsy Monitoring Devices Market: End Use Estimates & Trend Analysis

• 5.1. End Use Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Epilepsy Monitoring Devices Market by End Use Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Hospitals & Clinics
    • 5.4.1.1. Hospitals market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.4.2. Ambulatory Surgical Centers
    • 5.4.2.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.4.3. Neurology Centers
    • 5.4.3.1. Neurology Centers market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.4.4. Diagnostic Centers
    • 5.4.4.1. Diagnostic Centers market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 6. Epilepsy Monitoring Devices Market: Regional Estimates & Trend Analysis By Product, By End-use

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. North America
  • 6.5.2. U.S.
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
• 6.6. Europe
  • 6.6.1. Europe
  • 6.6.2. UK
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ Reimbursement
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. UK market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ Reimbursement
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Germany market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ Reimbursement
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. France market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework/ Reimbursement
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Italy market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Spain market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework/ Reimbursement
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.9. Norway
    • 6.6.9.1. Key country dynamics
    • 6.6.9.2. Regulatory framework
    • 6.6.9.3. Competitive scenario
    • 6.6.9.4. Norway market estimates and forecasts 2018 to 2030, (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific
  • 6.7.2. Japan
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ Reimbursement
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Japan market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ Reimbursement
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. China market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ Reimbursement
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. India market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.5. Australia
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ Reimbursement
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Australia market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.6. South Korea
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework/ Reimbursement
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Regulatory framework/ Reimbursement
    • 6.7.7.3. Competitive scenario
    • 6.7.7.4. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America
  • 6.8.2. Brazil
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework/ Reimbursement
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
• 6.9. MEA
  • 6.9.1. MEA
  • 6.9.2. South Africa
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework/ Reimbursement
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework/ Reimbursement
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework/ Reimbursement
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. UAE market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key country dynamics
    • 6.9.5.2. Regulatory framework
    • 6.9.5.3. Competitive scenario
    • 6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. NIHON KOHDEN CORPORATION
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Others benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Medtronic
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Others benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. GE Healthcare
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Others benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Koninklijke Philips N.V.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Others benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Compumedics Limited
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Others benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Natsu Medical
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Others benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Cadwell Industries, Inc.
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Others benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. BrainScope Company, Inc.
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Others benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Seer Medical
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Others benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Stratus
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Others benchmarking
    • 7.3.13.4. Strategic initiatives